Why it’s important to continue on VYNDAMAX® (tafamidis) as your doctor prescribed

clinical

In a clinical trial, VYNDAMAX was proven to significantly reduce death and the number of heart-related hospitalizations in people with ATTR-CM.

It’s important to remember that even if you don’t feel VYNDAMAX working, it can help you live longer with fewer hospital visits.

That’s because ATTR-CM is a disease that gets worse over time. VYNDAMAX works to help slow the progression of the disease by slowing the buildup of dangerous misfolded TTR protein.

Need help staying on track?

Learn about additional resources and support for VYNDAMAX.

Looking to speak to others living with ATTR-CM?

Advocacy groups are available to offer support.